Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments. - Oliveira Roster KI; Rönn MM; Gorenburg ER; Partl DK; Anderegg N; Abel Zur Wiesch P; Au C; Kouyos RD; Martinez FP; Low N; Grad YH (Open forum infectious diseases, 2026)